Tissue Regenix Group plc (AIM:TRX)
London · Delayed Price · Currency is GBP · Price in GBX 33.00
-0.50 (-1.49%)
Aug 5, 2025, 4:35 PM GMT+1
Accolade Revenue
In the year 2024, Tissue Regenix Group had annual revenue of $28.65M USD with 8.85% growth.
Revenue
$28.65M
Revenue Growth
+1.89%
P/S Ratio
1.03
Revenue / Employee
$311.37K
Employees
92
Market Cap
23.51M
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28.65M | 2.33M | 8.85% |
| Dec 31, 2023 | 26.32M | 1.84M | 7.52% |
| Dec 31, 2022 | 24.48M | 4.73M | 23.95% |
| Dec 31, 2021 | 19.75M | 3.27M | 19.87% |
| Dec 31, 2020 | 16.47M | -788.11K | -4.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.72B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
Tissue Regenix Group News
- 4 weeks ago - Tissue Regenix Group PLC (LSE:TRX) Full Year 2024 Earnings Call Highlights: Record Profit and ... - GuruFocus
- 4 weeks ago - Full Year 2024 Tissue Regenix Group PLC Earnings Call Transcript - GuruFocus
- 11 months ago - Tissue Regenix Group PLC (FRA:LSW) (Q2 2024) Earnings Call Transcript Highlights: Strong ... - GuruFocus